This Antibody AP08030PU detects endogenous levels of AKT1/AKT2/AKT3 only when phosphorylated at Tyrosine 315/316/312.
Purification
Affinity C Chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Immunogen
The antiserum was produced against synthesized phosphopeptide derived from human AKT1/AKT2/AKT3 around the phosphorylation site of Tyrosine 315/316/312 (P-E-YP-L-A).
AKT1
Reactivity: Human, Mouse, Rat, Monkey
WB, ELISA, IHC, IP
Host: Mouse
Monoclonal
17F6-B11
unconjugated
Application Notes
Immunofluorescence: 1/100-1/200. Immunohistochemistry on Paraffin-Embedded Sections: 1/50-1/100. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Concentration
1.0 mg/mL
Buffer
PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % Sodium Azide and 50 % Glycerol.
Preservative
Sodium azide
Precaution of Use
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
AKT1/2/3 are members of the AKT, also called PKB, serine/threonine protein kinase family. AKT kinases are known to be regulators of cell signaling in response to insulin and growth factors. They are involved in a wide variety of biological processes including cell proliferation, differentiation, apoptosis, tumorigenesis, as well as glycogen synthesis and glucose uptake.Synonyms: AKT-2, AKT-3 Review 010, Akt-1, C-AKT, PKB gamma, PKBG, Protein kinase B, RAC-PK-alpha, RAC-PK-beta, RAC-PK-gamma, RAC-alpha serine/threonine-protein kinase